Insulet International

Insulet (NASDAQ: PODD), headquartered in Massachusetts, is an innovative
medical device company dedicated to making the lives of people with diabetes
and other conditions easier through the use of its Omnipod® System product
platform. The Omnipod® System provides an alternative to traditional insulin
delivery methods. With its simple, wearable design, the disposable Pod
provides up to three days of non-stop insulin delivery, without the need to see
or handle a needle. Insulet also leverages the unique design of its Pod, by
tailoring its Omnipod® System technology platform for the delivery of non-insulin
subcutaneous drugs across multiple therapeutic areas. Founded in
2000, many users across the globe rely on Insulet’s Omnipod® System to
bring simplicity and freedom to their lives. For more information, please visit:
www.insulet.com, www.myomnipod.com

Company’s Keywords:

medical devices, diabetes, diabetic management, biotechnology, medical supply, advanced manufacturing, medical supply chain